A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients
2019 ◽
Vol 19
(1)
◽
pp. 47-51
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 6
(1)
◽
pp. 163-168
◽
Keyword(s):